An Innovative Approach Towards Understanding and Arresting Type 1 Diabetes (INNODIA)

UnknownOBSERVATIONAL
Enrollment

6,000

Participants

Timeline

Start Date

November 14, 2016

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Type 1 Diabetes Mellitus
Trial Locations (19)

Unknown

RECRUITING

Medical University of Graz, Graz

RECRUITING

Universitee Libre de Bruxelles, Brussels

RECRUITING

Katholieke Universiteit Leuven, Leuven

RECRUITING

University of Copenhagen, Copenhagen

RECRUITING

University of Helsinki, Helsinki

RECRUITING

University of Oulu, Oulu

NOT_YET_RECRUITING

Turku University Hospital, Turku

RECRUITING

Institut National de la Sante et de la Recherche Medicale (INSERM), Paris

RECRUITING

Children's Hospital Auf der Bult, Hannover Medical School, Hanover

RECRUITING

University of Ulm, Ulm

NOT_YET_RECRUITING

San Raffaele Hospital, Milan

RECRUITING

Ospedale Pediatrico Bambino Gesu, Rome

RECRUITING

University of Studi di Siena, Siena

RECRUITING

University of Luxembourg, Luxembourg

RECRUITING

Oslo Universitetssytehus HF, Oslo

RECRUITING

Medical University of Silesia Katowice, Katowice

RECRUITING

University of Ljubljana, Ljubljana

RECRUITING

University of Lund, Malmo

CB2 0QQ

RECRUITING

University of Cambridge, Cambridge

Sponsors
All Listed Sponsors
collaborator

Innovative Medicines Initiative

OTHER

collaborator

Juvenile Diabetes Research Foundation

OTHER

collaborator

The Leona M. and Harry B. Helmsley Charitable Trust

OTHER

lead

University of Cambridge

OTHER